* Retail distribution agreement for Nordics and UK with Norgesgruppen
* Successfull private offering on NOK 55 securing a good cash position to see company through to positive cash flow
* Enthustiastic Danish coverage of successfull animal experiments for antiviral inhalation treatment "Possible game changer, says University of Copenhagen"
Comes on top of previous news that the company received a 2 milln USD grant from the United States defence for their wound treatment product